Sept. 4, 2023

113. Best of: Recent Drug Approvals (vol. 1)! - Upadacitinib for AD - Tralokinumab for AD - Baricitinib for AA - Deucravacitinib for psoriasis - Spinosad for scabies

113. Best of: Recent Drug Approvals (vol. 1)! - Upadacitinib for AD - Tralokinumab for AD - Baricitinib for AA - Deucravacitinib for psoriasis - Spinosad for scabies
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon
Apple Podcasts podcast player iconSpotify podcast player iconYouTube podcast player iconOvercast podcast player iconPocketCasts podcast player iconRSS Feed podcast player icon

Best of: Recent Drug Approvals (vol. 1) -

Upadacitinib for AD (from episode 59) -

Tralokinumab for AD (from episode 73) -

Baricitinib for AA (from episode 87) -

Deucravacitinib for psoriasis (from episode 93) -

Spinosad for scabies (from episode 103)

Check out our video content on YouTube: Dermasphere Podcast - YouTube -

and VuMedi!: https://www.vumedi.com/channel/dermasphere/

The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare -

⁠⁠Connect with us!

- Web: ⁠https://dermaspherepodcast.com/⁠

- Twitter: @DermaspherePC

- Instagram: dermaspherepodcast

- Facebook: https://www.facebook.com/DermaspherePodcast/

- Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠

Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:

- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)

- ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)